share_log

2022年1月11日涨停板早知道:七大利好有望发酵

The trading limit of January 11, 2022 already knew that the seven benefits are expected to be fermented.

新浪財經綜合 ·  Jan 10, 2022 06:46

January 10 news, there are seven positive may affect tomorrow's stock market, specifically:

  Shanshui Bide: sign strategic cooperation agreement with fairy tale father and Huafu information

Shanshui Bide (300844) announced on the evening of January 10th that recently, the company signed a strategic cooperation agreement with Fairy Tale Dad and Huafu Information, and the parties intend to carry out strategic cooperation in many fields (including but not limited to meta-universe science and technology, meta-universe theme park, etc.).

  Weifu Hi-Tech: plans to set up a joint venture company for hydrogen fuel cell parts

Weifu Hi-Tech (000581) announced on the evening of January 10th that the company and its subsidiary IRD intend to jointly invest 500 million yuan with RBINT and New Kinetic Energy Fund to establish Wuxi Weifu hydrogen fuel Cell Technology Co., Ltd. Among them, the company contributed 225 million yuan (45%) with its own funds. On the basis of 500 million yuan of registered capital of the joint venture company, the follow-up company will continue to promote the Asia-Pacific base construction of hydrogen fuel cell core components business dominated by the joint venture company, with an additional investment of about 700 million yuan planned before 2025.

  Yunda shares: net profit in 2021 increased by 148.55% Rue 217.91% compared with the same period last year.

Yunda shares (300772) announced on the evening of January 10th that the company made a profit of 430 million yuan to 550 million yuan in 2021, an increase of 148.55% and 217.91% over the same period last year. During the reporting period, the company's orders increased significantly resulting in an increase in operating income, while the company's gross profit margin increased, and the company's operating performance increased significantly compared with the same period last year.

  Yuntianhua: net profit in 2021 is expected to increase by 1186.59% compared with the same period last year.

Yuntianhua (600096) announced on the evening of January 10th that the company expects the net profit attributable to shareholders of listed companies to be 3.5 billion yuan to 3.7 billion yuan in 2021, an increase of 1186.59% to 1260.11% over the same period last year. During the reporting period, the company's main chemical plants realized high-load operation, the unit energy consumption and material consumption of products were well controlled, and gave full play to the advantages of centralized procurement platform to accurately control the procurement rhythm of bulk raw materials such as sulfur and coal. the impact of rising prices of bulk raw materials has been effectively alleviated, and the competitive advantage of product cost has been continuously enhanced. The transformation and upgrading achievements of the company to fine phosphorus chemical industry, fluorine chemical industry and other non-fertilizer business are gradually emerging.

  Jingu Co., Ltd.: received the notice of selection of GAC Toyota Camry model supplier.

Jingu Co., Ltd. (002488) announced on the evening of January 10th that the company recently received a notice for the selection of a Camry model supplier from Guangzhou Automobile Toyota Motor Corp Co., Ltd. the company will act as the wheel supplier of GAC Toyota Camry models (including gas-electric hybrid models and traditional oil vehicles), the company will complete the mass production work in accordance with the requirements of GAC Toyota.

  Xin'an shares: net profit in 2021 increased by 344% Mel 362% compared with the same period last year.

Xin'an shares (600596) announced on the evening of January 10 that it is expected to make a net profit of 2.6 billion yuan to 2.7 billion yuan in 2021, an increase of 344% over the same period last year. During the reporting period, the prices of the company's major products, including glyphosate, silicone and industrial silicon, rose significantly compared with the same period last year, and the profit level increased significantly compared with the same period last year.

  Through the scene of life: COVID-19 test kit medical device registration accepted

Tuojing Life (300642) announced on the evening of January 10th that the company's 2019-nCoV nucleic acid detection kit (card fluorescent PCR method) medical device registration was accepted.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment